Open Door Community Health Centers in Samoa, CA - Clinic/Center

Open Door Community Health Centers is a primary clinic (Clinic/center - Federally Qualified Health Center (fqhc)) in Samoa, California. The current practice location for Open Door Community Health Centers is 26 Samoa Coast Ln, Samoa, California. For appointments, you can reach them via phone at (707) 443-4666. The mailing address for Open Door Community Health Centers is 1275 8th St, Arcata, California and phone number is (707) 826-8633.

Open Door Community Health Centers is licensed to practice in * (Not Available) (license number ) and its NPI number is 1215693338. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (707) 443-4666.

Contact Information

	Open Door Community Health Centers
	26 Samoa Coast Ln Samoa CA 95564-9535
	(707) 443-4666
	Not Available

Primary Care Clinic Profile

Full Name	Open Door Community Health Centers
Speciality	Clinic/center - Federally Qualified Health Center (fqhc)
Location	26 Samoa Coast Ln, Samoa, California
Authorized Official Name and Position	Stacy Watkins (VICE PRESIDENT OF ADMINISTRATION)
Authorized Official Contact	7078268633
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Open Door Community Health Centers 1275 8th St Arcata CA 95521-5770 Ph: (707) 826-8633	Open Door Community Health Centers 26 Samoa Coast Ln Samoa CA 95564-9535 Ph: (707) 443-4666

NPI Details:

NPI Number	1215693338
Provider Enumeration Date	11/12/2021
Last Update Date	11/12/2021

Medical Identifiers

Medical identifiers for Open Door Community Health Centers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215693338	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QF0400X	Clinic/center - Federally Qualified Health Center (fqhc)	(* (Not Available))	Primary

News Archive

Increased public awareness of cancer symptoms necessary to prevent avoidable deaths

One in seven people cannot name a single symptom of cancer, according to a Cancer Research UK survey published today (Monday).

Inovio's electroporation technology enhances ability of DNA therapy to stimulate blood vessel growth

Inovio Pharmaceuticals, Inc. announced today that the use of its proprietary electroporation technology significantly enhanced the ability of a DNA therapy to stimulate blood vessel growth, which may be beneficial for the treatment of critical limb ischemia and other forms of peripheral arterial disease.

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

Ovu-Trac kit for successful family planning

A recent British study revealed that over a third of the female test subjects could not recognize their own signs of fertility. Accurately identifying the signs of ovulation and how they relate to a woman's fertile phase is the key to successful family planning. However, just like anything else, it takes time to learn.

Potential benefits of Labopharm's novel trazodone formulation published

Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.

Open Door Community Health Centers - Primary Care in Samoa, CA